Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Anesthesia for patients with a history of malignant hyperthermia.

Wappler F.

Curr Opin Anaesthesiol. 2010 Jun;23(3):417-22. doi: 10.1097/ACO.0b013e328337ffe0. Review.

PMID:
20173632
2.

[Theophylline induces contractures in porcine skeletal muscle preparations with the disposition to malignant hyperthermia].

Gerbershagen MU, Fiege M, Weisshorn R, Kolodzie K, Wappler F.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2004 Mar;39(3):147-52. German.

PMID:
15042504
3.

Pathophysiological role of the serotonin system in malignant hyperthermia.

Wappler F, Fiege M, Schulte am Esch J.

Br J Anaesth. 2001 Nov;87(5):794-8. Review. No abstract available.

PMID:
11878537
4.

In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group.

Ording H, Brancadoro V, Cozzolino S, Ellis FR, Glauber V, Gonano EF, Halsall PJ, Hartung E, Heffron JJ, Heytens L, Kozak-Ribbens G, Kress H, Krivosic-Horber R, Lehmann-Horn F, Mortier W, Nivoche Y, Ranklev-Twetman E, Sigurdsson S, Snoeck M, Stieglitz P, Tegazzin V, Urwyler A, Wappler F.

Acta Anaesthesiol Scand. 1997 Sep;41(8):955-66.

PMID:
9311391
5.

Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action.

Sawynok J, Yaksh TL.

Pharmacol Rev. 1993 Mar;45(1):43-85. Review. No abstract available.

PMID:
8475169
6.

Biochemical changes in malignant hyperthermia susceptible swine: cyclic AMP, inositol phosphates, alpha 1, beta 1- and beta 2-adrenoceptors in skeletal and cardiac muscle.

Scholz J, Steinfath M, Roewer N, Patten M, Troll U, Schmitz W, Scholz H, Schulte am Esch J.

Acta Anaesthesiol Scand. 1993 Aug;37(6):575-83.

PMID:
8213023
7.

[Phosphodiesterase inhibition as a therapeutic principle].

Scholz H.

Z Kardiol. 1994;83 Suppl 2:1-5. Review. German.

PMID:
8091820
8.

Is theophylline, aminophylline, or caffeine (methylxanthines) contraindicated in malignant hyperthermia susceptible patients?

Flewellen EH, Nelson TE.

Anesth Analg. 1983 Jan;62(1):115-8. No abstract available.

PMID:
6849503
9.

A biochemical abnormality found in muscle from unstressed malignant-hyperpyrexia-susceptible humans.

Ellis FR, Halsall PJ, Allam P, Hay E.

Biochem Soc Trans. 1984 Jun;12(3):357-8. No abstract available.

PMID:
6734892
10.

Postoperative malignant hyperthermia episodes in patients who received "safe" anaesthetics.

Grinberg R, Edelist G, Gordon A.

Can Anaesth Soc J. 1983 May;30(3 Pt 1):273-6.

PMID:
6336548
11.

High skeletal muscle adenylate cyclase in malignant hyperthermia.

Willner JH, Cerri CG, Wood DS.

J Clin Invest. 1981 Nov;68(5):1119-24.

12.

Cyclic AMP in normal and malignant hyperpyrexia susceptible individuals following exercise.

Stanec A, Stefano G.

Br J Anaesth. 1984 Nov;56(11):1243-6.

PMID:
6091707
13.
14.

Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia.

Fujii J, Otsu K, Zorzato F, de Leon S, Khanna VK, Weiler JE, O'Brien PJ, MacLennan DH.

Science. 1991 Jul 26;253(5018):448-51.

PMID:
1862346
16.

Inositol-1,4,5-trisphosphate and malignant hyperthermia.

Scholz J, Troll U, Schulte am Esch J, Hartung E, Patten M, Sandig P, Schmitz W.

Lancet. 1991 Jun 1;337(8753):1361. No abstract available.

PMID:
1674350

Supplemental Content

Support Center